US TX Houston Quevedo J: Difference between revisions
From Bioblast
Beno Marija (talk | contribs) No edit summary Tag: Reverted |
Beno Marija (talk | contribs) No edit summary Tag: Manual revert |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{O2k-Network Lab | {{O2k-Network Lab | ||
|institution=The University of Texas | |institution=The University of Texas Medical School at Houston | ||
Medical School | Medical School | ||
Department of Psychiatry and Behavioral Sciences | |||
Department of Psychiatry and Behavioral Sciences | |||
|address=1941 East Road, Suite 5102 | |address=1941 East Road, Suite 5102 | ||
|area code=77054 | |area code=77054 | ||
Line 12: | Line 10: | ||
|state=Texas (TX) | |state=Texas (TX) | ||
|country=USA | |country=USA | ||
| | |Contact=Quevedo Joao | ||
|Status=O2k 2015- | |MiPNetLab=Scaini Giselli | ||
|Status=O2k 2015- | |||
|info=[[IOC106]] | |info=[[IOC106]] | ||
}} | }} | ||
[[Category:O2k-Network Labs USA]] | [[Category:O2k-Network Labs USA]] |
Latest revision as of 10:48, 7 February 2023
US TX Houston Quevedo J
O2k-Network Lab | The University of Texas Medical School at Houston
Medical School Department of Psychiatry and Behavioral Sciences |
---|---|
Address | 1941 East Road, Suite 5102, 77054 |
City | Houston |
State/Prov | Texas (TX) |
Country | USA |
Weblink | |
Contact | Quevedo Joao |
Team | Scaini Giselli |
Team previous | |
Status | O2k 2015- |
Oroboros Events | IOC106 |
Topics |
O2k-Publications
Published | Reference | |
---|---|---|
De Medeiros 2018 Biochim Biophys Acta | 2018 | de Medeiros WA, da Silva LA, Dall'Igna DM, Michels M, Manfredini A, Dos Santos Cardoso J, Constantino L, Scaini G, Vuolo F, Streck EL, Ritter C, Dal-Pizzol F (2018) N-acetylcysteine effects on a murine model of chronic critical limb ischemia. Biochim Biophys Acta 1864:454-63. |
Scaini 2018 Eur Neuropsychopharmacol | 2018 | Scaini G, Quevedo J, Velligan D, Roberts DL, Raventos H, Walss-Bass C (2018) Second generation antipsychotic-induced mitochondrial alterations: Implications for increased risk of metabolic syndrome in patients with schizophrenia. Eur Neuropsychopharmacol 28:369-80. |
O2k-Abstracts
update please